Lisdexamfetamine, often referred to as Vyvanse, is a scheduled medication approved for attention deficit hyperactivity disorder in children and adults . In Canada, its distribution is strictly regulated by https://teva-lisdexamfetamine-in355446.tribunablog.com/vyvanse-in-canada-a-detailed-guide-57994919